Abbott Laboratories Remains In Favor With London Investment Manager, New Filing ShowsThe Motley Fool • 10/15/25
Abbott Laboratories posts steady sales growth in Q3, reaffirms full-year guidanceProactive Investors • 10/15/25
Abbott Labs Skids On Mixed Third-Quarter Report, But One Segment ShinedInvestors Business Daily • 10/15/25
Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'Benzinga • 10/15/25
Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 10/13/25
Wall Street's Insights Into Key Metrics Ahead of Abbott (ABT) Q3 EarningsZacks Investment Research • 10/10/25
Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview)Seeking Alpha • 10/09/25
Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of DirectorsBusiness Wire • 10/06/25
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 10/03/25
Healthcare equipment stocks seen outperforming, ‘safer' than Big Pharma: analystsProactive Investors • 09/30/25